US Treasury Department (USDT) added India to its currency Monitoring List: Find out what this means in this edition of Big Story
The Securities and Exchange Board of India (Sebi) has made changes in the minimum public shareholding norms for listed companies that are going through the Corporate Insolvency Resolution Process in its recent board meeting. Here's all you need to know about the new rules.
The Health Ministry has issued operational guidelines for the COVID-19 vaccination drive. The standard operating procedure (SOP) has been shared with all states and Union territories. Watch the video to know more
Facebook is in for a long-drawn, vigorous battle that can cost it enormous resources. Dozens of US states, along with the United States Federal Trade Commission (FTC) and territory attorneys general, have sued the social media giant. Watch the video to find out what's next for the social media giant.
Real-time gross settlement (RTGS) services are set to be available for customers 24/7 from December 14. Here's all you need to know about the system.
As per the survey, Corporate India plans to hire more people in Q1CY2021 compared to the quarter ended December 2020. Watch the video to find out which sectors are on recruiters' radar
Petrol and diesel prices have been at the highest level since September 2018, It's now set to breach an all-time high. How much of it is tax? Let's find out in this edition of Big Story.
Serum Institute is now seeking the DCGI nod For emergency use authorisation of its vaccine candidate Covishield In India. More here.
Reserve Bank of India's monetary policy committee (MPC) will announce the outcome of its three-day bi-monthly meeting on December 4. Here's what to expect:
The gross Goods and Services Tax (GST) collection for November stood at Rs 1.04 lakh crore. GST collections were at Rs 1.05 lakh crore in October, making it the first time monthly revenues crossed the Rs 1 lakh crore mark in FY21. Is it likely that the GST collections can continue to be above Rs 1 lakh crore in the coming months? Let's Find out in this edition of Big Story
Cred, a credit card repayment app which has been in funding talks with various investors, has raised $80 million on a valuation of $800 million.
The 40-year-old volunteer claimed that he contracted severe neurological disorders after being vaccinated with Covidshield shots under development at Serum Institute of India. All you need to know about the legal hassle.
India has formally entered a technical recession as the GDP contracted for the second consecutive quarter. Let's find out what this means for the Indian economy:
In a bid to push infrastructure creation in the country, the Union Cabinet has approved Rs.6000 crore capital infusion in National Investment and Infrastructure Fund's (NIIF) debt platform over the next two years. How this move will play a role in infrastructure financing? Let's find out
S&P Global Ratings has said that Non-performing assets in the Indian banking sector are likely to witness an uptick and may shoot up to 11 percent of gross loans in the next 12-18 months. What does this mean for the banking system? Let's find out
Oil prices rose more than 1% on Nov 23, extending last week's gains as traders anticipated coronavirus vaccine trials would spur a recovery in demand. OPEC officials will meet this week on November 25, November 26 and November 27. Let's find out what we can expect in the upcoming meet
The last two weeks have seen a string of encouraging results from COVID-19 vaccine trials with several experimental vaccines having proved over 90% effectiveness at preventing disease in late-stage clinical trials. Let's find out if the hunt for the vaccine over
Pharmaceutical giant Pfizer Inc and its partner BioNTech SE are all set to seek emergency authorisation for its COVID-19 vaccine.
Global brokerage house Goldman Sachs recently revised India’s FY21 GDP target to 10.3 percent contraction as against earlier forecast of 14.8 percent contraction. The brokerage also said it will be overweight on Indian equities, and cited the macro recovery and relatively higher sensitivity of Indian stocks to positive vaccine outcomes.
With American pharma giant Moderna claiming that its experimental vaccine is effective in preventing COVID-19, it has become the second firm after the Pfizer vaccine to release late-stage trial results.
Union Finance Minister Nirmala Sitharaman on Nov 12 rolled out 12 measures as part of the Atmanirbhar Bharat 3.0 stimulus package worth Rs 1.2 lakh crore to boost the economy.
The Union Cabinet approved the production-linked incentive (PLI) scheme for 10 sectors on November 11. How does this scheme help these sectors? Let’s find out in this edition of Big Story.
The anti-China sentiment that grew in the wake of the Galwan valley clash seems to have died down as Chinese products are sparkling Diwali markets in India. What is driving consumers to these products? Let’s find out in this edition of Big Story.
US drug major Pfizer and German biotech firm BioNTech have pleasantly surprised the world on November 9 by announcing that their potential COVID-19 vaccine was found to be more than 90 percent effective in tackling the novel coronavirus. What do the early results say? How much can Pfizer produce, will it be available in India? How much will the vaccine cost? Here are five key things to know about Pfizer COVID-19 vaccine.
With Joe Biden becoming the 46th president of the United States, how will it impact bilateral relations between India and the US? Let’s find out in this edition of Big Story.